Coherus BioSciences News - CHRS

Company Name	Stock Ticker Symbol	Market	Type
Coherus BioSciences Inc	CHRS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	2.02	04:57:43

Open Price	Low Price	High Price	Close Price	Prev Close
				2.02

more quote information »

Recent News

Date	Time	Source	Heading
4/24/2024	10:02	GLOBE	Coherus Announces Presentation at the 2024 American Society..
4/08/2024	08:30	GLOBE	Coherus Presents Preclinical Data for CHS-1000, a Novel..
3/13/2024	16:01	GLOBE	Coherus BioSciences Reports Fourth Quarter, Full Year 2023..
3/05/2024	16:01	GLOBE	Coherus to Report Fourth Quarter and Full Year 2023..
3/04/2024	06:22	EDGAR2	Form 8-K - Current report
3/04/2024	01:00	GLOBE	Coherus Completes Divestiture of Ophthalmology Franchise
2/23/2024	17:33	GLOBE	Coherus BioSciences Announces New Employment Inducement..
2/22/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	17:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2/22/2024	16:59	EDGAR2	Form 8-K - Current report
2/21/2024	08:30	GLOBE	Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
2/05/2024	08:09	EDGAR2	Form 8-K - Current report
2/05/2024	08:00	GLOBE	Coherus Amends Term Loan Agreement with Pharmakon Advisors,..
1/23/2024	20:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/23/2024	20:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/22/2024	08:01	EDGAR2	Form 8-K - Current report
1/22/2024	01:59	DJN	Sandoz to Acquire Cimerli Business from Coherus for $170..
1/22/2024	01:15	GLOBE	Coherus Announces Agreement to Divest Ophthalmology..
1/18/2024	16:05	GLOBE	Coherus Presents Positive Phase 2 Clinical Data on..
1/09/2024	21:41	EDGAR2	Form 8-K - Current report
1/09/2024	21:39	EDGAR2	Form 8-K - Current report
1/09/2024	19:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	18:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	17:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	17:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	08:00	PRNUS	INOVIO and Coherus Announce Clinical Collaboration to..
1/03/2024	16:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	09:00	GLOBE	Coherus BioSciences Management to Present at the 42nd Annual..
1/02/2024	08:29	GLOBE	Coherus Announces U.S. Launch of LOQTORZI™
12/27/2023	09:15	APS	Another Biotech Massively Outperforming Broader Equities
12/27/2023	06:08	IHMARKETNEWS	Wall Street Highlights: Apple Appeals Watch Ban, Tesla to..
12/26/2023	16:43	DJN	Coherus BioSciences Gets FDA OK for Udenyca Injector
12/26/2023	16:01	GLOBE	Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel..
12/22/2023	17:00	GLOBE	Coherus BioSciences Announces New Employment Inducement..
12/15/2023	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/11/2023	16:13	EDGAR2	Form 8-K - Current report
12/11/2023	08:30	GLOBE	Coherus Announces Updated NCCN Clinical Practice Guidelines..
12/07/2023	17:55	GLOBE	Coherus BioSciences Announces CFO Transition Plans
12/07/2023	17:16	EDGAR2	Form 8-K - Current report
12/06/2023	04:00	GLOBE	Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a..
11/28/2023	11:16	GLOBE	Coherus and Junshi Biosciences Announce Publication of..
11/27/2023	16:03	EDGAR2	Form 8-K - Current report
11/13/2023	06:07	EDGAR2	Form 8-K/A - Current report: [Amend]
11/06/2023	16:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	16:31	EDGAR2	Form 8-K - Current report
11/06/2023	16:07	GLOBE	Coherus BioSciences Reports Third Quarter 2023 Financial..
11/06/2023	06:07	EDGAR2	Form 8-K/A - Current report: [Amend]
11/03/2023	08:30	GLOBE	Coherus Presents Data from Next-generation Immuno-oncology..
11/02/2023	20:00	GLOBE	Coherus BioSciences to Participate at Upcoming November..
10/30/2023	18:00	GLOBE	Coherus BioSciences to Report Third Quarter 2023 Financial..